Publications by authors named "Yoko Franchetti"

Claim this Profile
P
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic Rhinitis.
Mohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, Christine Xu, Claire Q Wang

J Clin Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical Equations.
Yoko Franchetti

J Clin Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance Pathways.
Yoko Franchetti, Thomas D Nolin

J Clin Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation.
Yoko Franchetti, Thomas D Nolin

J Clin Pharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of CO Production Rate Data.
Yoko Franchetti, Thomas D Nolin

J Pharmacol Exp Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
Heather A Jacene, Trisha Youn, Pamela J DiPiro, Jiani Hu, Su-Chun Cheng, Yoko Franchetti

Clin Breast Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimethylamine -Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis.
Jason R Stubbs, Margaret R Stedman, Sai Liu, Jin Long, Yoko Franchetti

Clin J Am Soc Nephrol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.
James D Luketich, Arjun Pennathur, Yoko Franchetti, Paul J Catalano, Scott Swanson

Ann Surg· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.
Katherine M Krajewski, Yoko Franchetti, Mizuki Nishino, André P Fay, Nikhil Ramaiya

Oncologist· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socio-demographic and lifestyle factors for child's physical growth and adiposity rebound of Japanese children: a longitudinal study of the 21st century longitudinal survey in newborns.
Yoko Franchetti, Hiroo Ide

BMC Public Health· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adaptive two-stage dose-response design method for establishing proof of concept.
Yoko Franchetti, Stewart J Anderson, Allan R Sampson

J Biopharm Stat· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.
Katherine M Krajewski, Mizuki Nishino, Yoko Franchetti, Nikhil H Ramaiya, Annick D Van den Abbeele

Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.
Mariella Gruber Filbin, Sukriti K Dabral, Maria F Pazyra-Murphy, Shakti Ramkissoon, Andrew L Kung, Yoko Franchetti

Nat Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
Zhao Chen, Katherine Cheng, Zandra Walton, Yuchuan Wang, Hiromichi Ebi, Yoko Franchetti

Nature· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis